Classification of idiopathic inflammatory myopathies: pathology perspectives

被引：62

作者：

Tanboon, Jantima ^{[1
]}

Nishino, Ichizo ^{[1
,2
,3
]}

机构：

[1] NCNP, Dept Neuromuscular Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878502, Japan

[2] NCNP, Dept Genome Med Dev, Kodaira, Tokyo, Japan

[3] NCNP, Dept Clin Genome Anal, MGC, Kodaira, Tokyo, Japan

来源：

CURRENT OPINION IN NEUROLOGY | 2019年 / 32卷 / 05期

关键词：

antisynthetase syndrome; dermatomyositis; immune-mediated necrotizing myopathy; inclusion body myositis; myositis-specific antibody; INCLUSION-BODY MYOSITIS; AUTOANTIBODIES; ANTIBODY; DERMATOMYOSITIS; ADULT; NAARDEN; DISEASE; POLYMYOSITIS; DIAGNOSIS; SEVERITY;

D O I：

10.1097/WCO.0000000000000740

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Purpose of review Idiopathic inflammatory myopathies (IIM) are rare diseases with heterogenous clinicopathological features. In recent years, new classification systems considering various combinations of clinical, serological, and pathological information have been proposed. This review summarizes recent clinicoseropathological development in major subgroups of IIM. Recent findings Considering clinicoseropathological features, IIM are suggestively classified into four major subgroups: dermatomyositis, immune-mediated necrotizing myopathy (IMNM), antisynthetase syndrome (ASS), and inclusion body myositis (IBM). Many historically diagnosed polymyositis have been mainly reclassified as IBM, IMNM, and ASS. Different types of myositis-specific antibodies (MSA) suggest distinct clinicopathological subsets of IIM. Excluding IBM, at least one-third of the IIMs have no known associated MSA. MSA are crucial for IIM classification but can be negative. Thus, IIM should be universally classified using stepwise or integrated information on clinical, serological, and pathological findings.

引用

页码：704 / 714

页数：11

共 70 条

[31] Absence of sarcoplasmic myxovirus resistance protein A (MxA) expression in antisynthetase syndrome in a cohort of 194 cases [J].

Inoue, M. ;

Tanboon, J. ;

Okubo, M. ;

Theerawat, K. ;

Saito, Y. ;

Ogasawara, M. ;

Indrawati, L. A. ;

Uruha, A. ;

Okiyama, N. ;

Fujimoto, M. ;

Suzuki, S. ;

Nishino, I. .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2019, 45 (05) :523-524

[32] Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy [J].

Kadoya, Masato ;

Hida, Ayumi ;

Maeda, Meiko Hashimoto ;

Taira, Kenichiro ;

Ikenaga, Chiseko ;

Uchio, Naohiro ;

Kubota, Akatsuki ;

Kaida, Kenichi ;

Miwa, Yusuke ;

Kurasawa, Kazuhiro ;

Shimada, Hiroyuki ;

Sonoo, Masahiro ;

Chiba, Atsuro ;

Shiio, Yasushi ;

Uesaka, Yoshikazu ;

Sakurai, Yasuhisa ;

Izumi, Toru ;

Inoue, Manami ;

Kwak, Shin ;

Tsuji, Shoji ;

Shimizu, Jun .

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (06)

[33]

Kubínová K, 2018, CLIN EXP RHEUMATOL, V36, pS74

[34] Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features [J].

Kurtzman, Drew J. B. ;

Vleugels, Ruth Ann .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (04) :776-785

[35] JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis [J].

Ladislau, Leandro ;

Suarez-Calvet, Xavier ;

Toquet, Segolene ;

Landon-Cardinal, Oceane ;

Amelin, Damien ;

Depp, Marine ;

Rodero, Mathieu P. ;

Hathazi, Denisa ;

Duffy, Darragh ;

Bondet, Vincent ;

Preusse, Corinna ;

Bienvenu, Boris ;

Rozenberg, Flore ;

Roos, Andreas ;

Benjamim, Claudia F. ;

Gallardo, Eduard ;

Illa, Isabel ;

Mouly, Vincent ;

Stenzel, Werner ;

Butler-Browne, Gillian ;

Benveniste, Olivier ;

Allenbach, Yves .

BRAIN, 2018, 141 :1609-1621

[36] New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter [J].

Leclair, Valerie ;

Lundberg, Ingrid E. .

CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (04)

[37] Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies [J].

Liang, Wen-Chen ;

Uruha, Akinori ;

Suzuki, Shigeaki ;

Murakami, Nobuyuki ;

Takeshita, Eri ;

Chen, Wan-Zi ;

Jong, Yuh-Jyh ;

Endo, Yukari ;

Komaki, Hirofumi ;

Fujii, Tatsuya ;

Kawano, Yutaka ;

Mori-Yoshimura, Madoka ;

Oya, Yasushi ;

Xi, Jianying ;

Zhu, Wenhua ;

Zhao, Chongbo ;

Watanabe, Yurika ;

Ikemoto, Keisuke ;

Nishikawa, Atsuko ;

Hamanaka, Kohei ;

Mitsuhashi, Satomi ;

Suzuki, Norihiro ;

Nishino, Ichizo .

RHEUMATOLOGY, 2017, 56 (02) :287-293

[38] Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy [J].

Lim, Johan ;

Rietveld, Anke ;

De Bleecker, Jan L. ;

Badrising, Umesh A. ;

Saris, Christiaan G. J. ;

van der Kooi, Anneke J. ;

de Visser, Marianne .

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (01)

[39] Evaluation and construction of diagnostic criteria for inclusion body myositis [J].

Lloyd, Thomas E. ;

Mammen, Andrew L. ;

Amato, Anthony A. ;

Weiss, Michael D. ;

Needham, Merrilee ;

Greenberg, Steven A. .

NEUROLOGY, 2014, 83 (05) :426-433

[40] Classification of myositis [J].

Lundberg, Ingrid E. ;

de Visser, Marianne ;

Werth, Victoria P. .

NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (05) :269-278

← 1 2 3 4 5 6 7 →